A prospective study including women with normal biopsy, various grades of cervical precancerous lesions, and cases of cervical cancer reported that the positivity rates for all three genes were similarly high in CIN3 and cervical cancer cases and similarly low in low-grade lesions and normal histology samples (51.6% and 57.4% vs. 10.5% and 0.0% for CADM1; p < 0.001; 60.0% and 92.8% vs. 10.5% and 0.0% for MAL; p < 0.001; 68.3% and 78.5% vs. 15.7% and 12.5% for miR124; p < 0.001) [93]. This evidence concerns the gene CADM1 and cervical carcinoma.